Nanosphere Targets $23.4M in Public Offering | GenomeWeb

NEW YORK (GenomeWeb News) – Nanosphere today said that it plans to offer 10.5 million shares of its common stock at $2.40 per share in a public offering.

The offering is expected to bring in net proceeds of about $23.4 million. It has granted its underwriters a 30-day option to purchase up to 1.575 million additional shares of common stock to cover any overallotments. If the option is exercised, net proceeds are expected to be about $26.9 million.

The offering is expected to close on July 24.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Prosecutors seek to introduce evidence from low-template DNA analysis in a murder case in upstate New York, the New York Times reports.

In PNAS this week: map of UV-induced damage in yeast genome, comparative epigenomics uncovers plant lacking key DNA methyltransferase enzyme, and more.

Researchers kick off their second Queer in STEM survey to examine what can make STEM careers welcoming, Wired reports.

A startup company is offering a test to analyze soil samples from farms for pathogens.